(5R)-8-Chloro-3-methyl-5-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-ol (2Z)-2-butenedioate (1:1)(CAS: 87134-87-0)

This compound is subject to various regulatory guidelines depending on its intended use. Globally, it must comply with GHS classification for hazardous substances. In the European Union, it falls under REACH regulations, which require detailed safety data sheets and registration. FDA and EPA regulations may also apply, especially if it is used in pharmaceuticals or agricultural products. Ensure compliance with local and international standards for proper handling, storage, and disposal.

Alternatives to this compound may include structurally similar compounds such as (5R)-8-chloro-3-methyl-5-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-ol or its isomers. In synthesis, other reagents like azide derivatives or chloroalkanes can be used as substitutes, depending on the specific reaction conditions and desired product. Always consider the availability and cost-effectiveness of these alternatives.

The market for this compound shows growing interest in its application in pharmaceuticals and research, particularly in drug discovery and development. Research trends indicate increasing exploration of its biological activities and potential therapeutic applications. Market dynamics suggest a steady demand, driven by its unique chemical properties and emerging research trends.

Waste containing this compound should be handled according to local and international hazardous waste management regulations. Collect waste in appropriate containers, ensuring it is labeled with the correct hazard symbols. For disposal, consider professional waste treatment facilities. Incineration or chemical treatment may be necessary, depending on the local regulations. Always follow safety precautions to prevent environmental contamination and ensure worker safety.